BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension
医学
心脏病学
内科学
肺动脉高压
体质指数
作者
Breanne E. McCarthy,Robyn L. McClelland,Dina Appleby,Jude Moutchia,Jasleen Minhas,Jeff Min,Jeremy A. Mazurek,K. Akaya Smith,Jason S. Fritz,Steven C. Pugliese,Ryan J. Urbanowicz,John H. Holmes,Harold I. Palevsky,Steven M. Kawut,Nadine Al‐Naamani
Obesity is increasingly prevalent in pulmonary arterial hypertension (PAH) but is associated with improved survival, creating an "obesity paradox" in PAH. It is unknown if the improved outcomes could be attributable to obese patients deriving a greater benefit from PAH therapies.